Regulatory Science Ireland: bridging the information gap on biosimilar medicines

摘要

Regulatory Science Ireland (RSI) is a voluntary network of interested parties from academia, the Health Products Regulatory Authority(HPRA), pharmaceutical and medical device industries and government agencies. RSI is conducting a research project, the objectiveof which is to enhance understanding of biosimilar medicines amongst stakeholders and encourage best practice in the use of thesemedicines.